Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Post by teeveeon Jul 26, 2010 1:06pm
558 Views
Post# 17297068

Is Lux in a bad spot?

Is Lux in a bad spot?If the FDA decision effectively delays approvals, there are a few  questions that come to mind:
1. How long can ISA keep the doors open?
2. If ISA goes under, does  Lux's deal with ISA die?
3. If Lux's deal dies with ISA, does Lux have a side bar deal with Paladin, or is Lux effectively forced to support ISA by advancing some of the milestone payments early in exchange for some sort of renegotiated deal? 
4. Would it make any sense for Lux to do a reverse takeover of ISA? 
  
<< Previous
Bullboard Posts
Next >>